SOPHiA GENETICS Expands Relationship with Città della Salute e della Scienza di Torino

SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space and a leader in data-driven medicine, today announced the expansion of its relationship with the Città della Salute e della Scienza di Torino located in Turin, Italy. The hospital, which used SOPHiA GENETICS after a public tender in 2021 to optimize workflows and support research in the areas of hereditary cancer, neurological disorders, solid tumors, hematology and rare disease, will further expand its usage

Related Keywords

Turkey ,Barbara Pasini ,Elena Bonfiglioli ,Kevin Puylaert ,Microsoft ,Instagram ,Facebook ,Research Use ,Nasdaq ,Linkedin ,Molecular Pathology Laboratory ,Life Sciences ,Medical Genetics Unit ,Microsoft Azure ,Microsoft Azure Powered ,Managing Director ,General Manager ,Global Pharma ,Research Use Only ,Vitro Diagnostic Use ,Turkey The ,Looking Statements ,Sophia Genetics ,Ittà Della Salute ,Genomic Data ,Coscienza ,Cloud Infrastructure ,Support Research ,Precision Medicine ,Data Driven ,